Novo Nordisk Receives Approval for New FlexTouch Pen in Europe
By Adam Brown
Although insulin pens don't often grab headlines as much as other diabetes devices, we were glad to hear news about Novo Nordisk’s FlexTouch pen earlier this summer. The pen received European approval in July and has been submitted for approval in the US. What’s newsworthy is the pen’s novel delivery mechanism: the FlexTouch uses an “easy-touch” button to deliver insulin, which according to Novo Nordisk, requires very little force to inject the insulin. We hope this will represent an improvement over current pens that rely on the variable force of a user’s thumb to push the button and deliver the insulin. The pen will also provide an audible click when the injection has completed, informing users when their full insulin dose has been given. We know that injecting insulin is not easy, even with the best pens, and we love that Novo Nordisk is trying to soften the sting. We look forward to hearing more about the new pen, especially once it gains approval in the US. --DZ/AB
